Journal rankings · indicator year 2017
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2017
Immunology journal rankings 2017
96 ranked journals · Subfield in Immunology and Microbiology
Immunology has 96 ranked journals in 2017. The median OJR fell 0.10 on 2016 to 0.95, below the world average of 1.00; Q1 starts at OJR 1.44. The top three are Immunity, Nature Immunology, and The Journal of Experimental Medicine.
Ranks and citation indicators: 2017. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2014–2016, the window the 2017 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Immunology and Microbiology (5)
96 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2016. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2014–2016, the window the 2017 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2014–2016 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2008 to 2017. | Compare |
|---|---|---|---|---|---|---|---|
1ImmunityCell Press · United States | 6.21Q1 | 16.52 1.71 down from 2016 | 759 | 95% | $10,400 | ||
2Nature ImmunologyNature Portfolio · United States | 4.68Q1 | 13.48 0.95 up from 2016 | 762 | 42% | $12,690 | ||
3The Journal of Experimental MedicineRockefeller University Press · United States | 3.48Q1 | 9.60 0.56 down from 2016 | 720 | 99% | — | ||
4Science ImmunologyAmerican Association for the Advancement of Science · United States | 3.40Q1 | 8.39no 2016 value | 38 | 59% | — | — | |
5Seminars in ImmunologyElsevier BV · United States | 3.38Q1 | 8.62 1.90 down from 2016 | 174 | 52% | $4,370 | ||
6Journal of Allergy and Clinical ImmunologyElsevier BV · United States | 3.20Q1 | 8.26 0.42 down from 2016 | 1,677 | 63% | $4,900 | ||
7Nature reviews. ImmunologyNature Portfolio · United Kingdom | 3.15Q1 | 19.84 3.08 up from 2016 | 485 | 21% | — | ||
8Journal of AutoimmunityElsevier BV · United Kingdom | 3.15Q1 | 8.25 1.01 down from 2016 | 350 | 44% | $5,420 | ||
9Annual Review of ImmunologyAnnual Reviews · United States | 2.74Q1 | 24.64 10.67 down from 2016 | 71 | 88% | — | ||
10Current Protocols in ImmunologyWiley · United States | 2.69Q1 | 8.03no change | 50 | 8% | $5,050 | ||
11Mucosal ImmunologyOAElsevier BV · United States | 2.62Q1 | 7.03 0.75 up from 2016 | 393 | 100% | $4,370 | ||
12Clinical & Translational ImmunologyOAWiley · Australia | 2.61Q1 | 6.58 1.32 up from 2016 | 112 | 100% | $3,070 | ||
13Seminars in ImmunopathologySpringer Science+Business Media · Germany | 2.59Q1 | 6.42 0.80 up from 2016 | 191 | 60% | $3,790 | ||
14Clinical Reviews in Allergy & ImmunologySpringer Nature · United States | 2.55Q1 | 7.10 1.70 up from 2016 | 184 | 29% | $5,490 | ||
15Frontiers in ImmunologyOAFrontiers Media · Switzerland | 2.29Q1 | 6.41 0.60 down from 2016 | 1,931 | 100% | $3,801 | ||
16Journal of Innate ImmunityOAKarger Publishers · Switzerland | 2.14Q1 | 7.02 3.58 up from 2016 | 193 | 100% | $3,590 | ||
17Cellular and Molecular ImmunologySpringer Nature · China | 1.87Q1 | 5.85 1.99 up from 2016 | 320 | 100% | $5,190 | ||
18The Journal of ImmunologyAmerican Association of Immunologists · United States | 1.72Q1 | 4.72 0.58 down from 2016 | 3,491 | 20% | $3,500 | ||
19Immunity & AgeingOABioMed Central · United Kingdom | 1.61Q1 | 5.37 2.61 up from 2016 | 81 | 100% | $3,190 | ||
20The AAPS JournalSpringer Science+Business Media · United States | 1.61Q1 | 3.52 0.26 down from 2016 | 448 | 44% | $5,090 | ||
21International Journal of InflammationOAHindawi Publishing Corporation · United Kingdom | 1.57Q1 | 3.57 0.17 down from 2016 | 50 | 100% | $1,000 | ||
22BioDrugsAdis, Springer Healthcare · Switzerland | 1.50Q1 | 4.99 1.39 up from 2016 | 114 | 52% | $5,190 | ||
23Journal of Leukocyte BiologyOxford University Press · United States | 1.48Q1 | 4.26 0.03 down from 2016 | 681 | 46% | $3,800 | ||
24Expert Opinion on Biological TherapyTaylor & Francis · United Kingdom | 1.44Q1 | 4.00 0.40 up from 2016 | 473 | 27% | — | ||
25Clinical & Experimental ImmunologyOxford University Press · United Kingdom | 1.37Q2 | 3.90 0.27 up from 2016 | 653 | 93% | $3,816 | ||
26CytokineElsevier BV · United Kingdom | 1.31Q2 | 3.43 0.21 down from 2016 | 817 | 25% | $3,220 | ||
27Immunology and Cell BiologyWiley · Australia | 1.29Q2 | 3.16 0.30 down from 2016 | 383 | 53% | $3,750 | ||
28European Journal of ImmunologyWiley · Germany | 1.28Q2 | 3.55 0.09 down from 2016 | 1,027 | 68% | $4,550 | ||
29Clinical ImmunologyElsevier BV · Netherlands | 1.27Q2 | 3.32 0.75 down from 2016 | 534 | 28% | $4,400 | ||
30ImmunologyWiley · United Kingdom | 1.25Q2 | 3.85 0.54 up from 2016 | 482 | 74% | $5,330 | ||
31Trends in ImmunologyElsevier BV · United Kingdom | 1.25Q2 | 11.99 1.58 up from 2016 | 286 | 64% | $7,030 | ||
32Immunologic ResearchSpringer Science+Business Media · United States | 1.25Q2 | 2.74 0.11 down from 2016 | 380 | 18% | $2,890 | ||
33Molecular ImmunologyElsevier BV · Netherlands | 1.23Q2 | 3.30 0.42 down from 2016 | 758 | 18% | $3,340 | ||
34American Journal of Reproductive ImmunologyWiley · United Kingdom | 1.23Q2 | 3.07 0.04 up from 2016 | 368 | 28% | $4,460 | ||
35Journal of Clinical ImmunologySpringer Science+Business Media · United States | 1.22Q2 | 4.16 0.01 up from 2016 | 382 | 41% | $4,990 | ||
36Cellular ImmunologyElsevier BV · Netherlands | 1.15Q2 | 3.22 0.20 down from 2016 | 339 | 31% | $3,550 | ||
37BMC ImmunologyOABioMed Central · United Kingdom | 1.14Q2 | 3.33 0.10 up from 2016 | 179 | 100% | $3,090 | ||
38Drugs in R&DOAAdis, Springer Healthcare · New Zealand | 1.13Q2 | 3.05 0.19 up from 2016 | 119 | 100% | $3,490 | ||
39International Reviews of ImmunologyTaylor & Francis · United States | 1.13Q2 | 2.72 0.14 down from 2016 | 87 | 31% | — | ||
40Immune NetworkOASouth Korea | 1.13Q2 | 3.13 0.29 down from 2016 | 124 | 100% | — | ||
41Inflammation ResearchSpringer Science+Business Media · Switzerland | 1.10Q2 | 2.92 0.13 up from 2016 | 315 | 17% | $4,790 | ||
42Inflammation & Allergy - Drug TargetsBentham Science Publishers · Netherlands | 1.10Q2 | 1.81 0.51 down from 2016 | 63 | — | — | ||
43ImmunobiologyOAElsevier BV · Germany | 1.06Q2 | 2.89 0.07 down from 2016 | 488 | 23% | $2,840 | ||
44Immunology LettersElsevier BV · Netherlands | 1.05Q2 | 2.52 0.50 down from 2016 | 499 | 23% | $3,290 | ||
45Genes and ImmunitySpringer Nature · United States | 1.05Q2 | 2.66 0.27 down from 2016 | 191 | 41% | $3,190 | ||
46Immunological ReviewsWiley · United States | 0.99Q2 | 10.75 0.28 up from 2016 | 307 | 64% | $5,000 | ||
47Journal of Interferon & Cytokine ResearchMary Ann Liebert, Inc. · United States | 0.98Q2 | 2.29 0.33 down from 2016 | 263 | 24% | — | ||
48Innate ImmunityOASAGE Publishing · United Kingdom | 0.97Q2 | 2.50 0.01 down from 2016 | 159 | 64% | $2,650 | ||
49Developmental & Comparative ImmunologyElsevier BV · United Kingdom | 0.94Q3 | 3.14 0.17 down from 2016 | 681 | 22% | $3,340 | ||
50Journal of Immunological MethodsElsevier BV · Netherlands | 0.91Q3 | 2.29 0.27 down from 2016 | 474 | 40% | $2,970 |
Subfields of Immunology and Microbiology, with Immunology highlighted.
Journals
Citations made in 2017. Corpus-wide, 77.7% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
30 additional Immunology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2014–2016, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2017. Publication window: 2014–2016. How these summaries are calculated
- Ranked journals
- 96
- Window papers (baseline)
- 72,790 +3.0% from indicator year 2014
- Median OJR
- 0.95 -11.5% from indicator year 2014
- Rising journals (2025)
- 5
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2014–2016 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 56 | 59 | 63 | 65 | 62 | 64 | 68 | 72 | 71 | 74 | 76 | 79 | 81 | 86 | 83 | 88 | 90 | 96 | 94 | 90 | 92 | 87 | 88 | 88 | 88 | 86 | |
| Window papers (baseline) | 33,673 | 35,811 | 37,963 | 40,362 | 42,065 | 44,849 | 47,600 | 50,960 | 53,923 | 57,726 | 63,072 | 65,596 | 67,601 | 67,579 | 70,684 | 72,624 | 73,354 | 72,790 | 72,098 | 72,447 | 74,045 | 77,362 | 81,615 | 83,779 | 84,353 | 84,391 | |
| Median OJR | 0.72 | 0.78 | 0.834 | 0.82 | 0.830 | 0.88 | 0.89 | 0.959 | 1.002 | 1.15 | 1.100 | 1.09 | 1.096 | 1.04 | 1.08 | 1.06 | 1.05 | 0.95 | 0.921 | 0.970 | 0.931 | 0.932 | 0.967 | 0.956 | 0.922 | 0.87 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.